QL
FOLD

Quarry LP’s Amicus Therapeutics FOLD Stock Holding History

Quarry LP’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668K Buy
46,220
+9,940
+27% +$142K 0.12% 128
2025
Q4 		$517K Buy
36,280
+34,288
+1,721% +$337K 0.08% 131
2025
Q3 		$15.7K Buy
+1,992
New +$14.2K ﹤0.01% 1527

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Quarry LP's FOLD Position: Q1 2026 in Review

Quarry LP increased its Amicus Therapeutics (FOLD) stake by 27% in Q1 2026, buying an estimated $142K and bringing the position to 46,220 shares worth $668K. The position accounts for 0.12% of the portfolio, ranked #128.

Quarry LP first reported a position in FOLD in Q3 2025 and has held it in 3 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Quarry LP held 46,220 shares of Amicus Therapeutics worth $668K as of Q1 2026.
  • Quarry LP bought 9,940 Amicus Therapeutics shares in Q1 2026, an estimated $142K.
  • Amicus Therapeutics made up 0.12% of Quarry LP's portfolio in Q1 2026, its #128 holding.
  • Quarry LP first reported a position in Amicus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.